Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs ABBOTT INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA ABBOTT INDIA DISHMAN PHARMA/
ABBOTT INDIA
 
P/E (TTM) x 30.0 50.0 60.0% View Chart
P/BV x 3.3 18.2 18.4% View Chart
Dividend Yield % 0.7 1.2 55.1%  

Financials

 DISHMAN PHARMA   ABBOTT INDIA
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
ABBOTT INDIA
Mar-23
DISHMAN PHARMA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs37422,482 1.7%   
Low Rs12916,156 0.8%   
Sales per share (Unadj.) Rs197.02,517.0 7.8%  
Earnings per share (Unadj.) Rs21.2446.8 4.7%  
Cash flow per share (Unadj.) Rs34.7479.7 7.2%  
Dividends per share (Unadj.) Rs2.00325.00 0.6%  
Avg Dividend yield %0.81.7 47.2%  
Book value per share (Unadj.) Rs179.91,480.5 12.1%  
Shares outstanding (eoy) m80.7021.25 379.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.37.7 16.6%   
Avg P/E ratio x11.943.2 27.5%  
P/CF ratio (eoy) x7.340.3 18.0%  
Price / Book Value ratio x1.413.0 10.7%  
Dividend payout %9.472.7 13.0%   
Avg Mkt Cap Rs m20,307410,513 4.9%   
No. of employees `000NANA-   
Total wages/salary Rs m5,3555,636 95.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,89853,487 29.7%  
Other income Rs m2651,543 17.2%   
Total revenues Rs m16,16355,030 29.4%   
Gross profit Rs m4,10312,055 34.0%  
Depreciation Rs m1,091700 155.9%   
Interest Rs m944160 590.6%   
Profit before tax Rs m2,33412,738 18.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6243,244 19.2%   
Profit after tax Rs m1,7109,494 18.0%  
Gross profit margin %25.822.5 114.5%  
Effective tax rate %26.725.5 104.9%   
Net profit margin %10.817.8 60.6%  
BALANCE SHEET DATA
Current assets Rs m11,01830,251 36.4%   
Current liabilities Rs m9,51712,060 78.9%   
Net working cap to sales %9.434.0 27.8%  
Current ratio x1.22.5 46.2%  
Inventory Days Days5787 65.6%  
Debtors Days Days32 161.7%  
Net fixed assets Rs m18,78715,135 124.1%   
Share capital Rs m161213 76.0%   
"Free" reserves Rs m14,35431,248 45.9%   
Net worth Rs m14,51631,460 46.1%   
Long term debt Rs m4,1890-   
Total assets Rs m29,80545,386 65.7%  
Interest coverage x3.580.7 4.3%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.51.2 45.3%   
Return on assets %8.921.3 41.9%  
Return on equity %11.830.2 39.0%  
Return on capital %17.541.0 42.7%  
Exports to sales %24.90.4 6,017.4%   
Imports to sales %3.710.8 34.7%   
Exports (fob) Rs m3,956221 1,788.5%   
Imports (cif) Rs m5945,765 10.3%   
Fx inflow Rs m4,952310 1,598.3%   
Fx outflow Rs m6975,818 12.0%   
Net fx Rs m4,255-5,508 -77.3%   
CASH FLOW
From Operations Rs m2,7868,934 31.2%  
From Investments Rs m-1,529-1,477 103.5%  
From Financial Activity Rs m-941-6,387 14.7%  
Net Cashflow Rs m3171,070 29.6%  

Share Holding

Indian Promoters % 61.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 23.0 8.9 257.3%  
FIIs % 12.0 0.2 6,650.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 25.0 154.3%  
Shareholders   52,291 72,252 72.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs Abbott India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Abbott India Share Price Performance

Period Dishman Pharma Abbott India S&P BSE HEALTHCARE
1-Day 2.87% 0.74% 1.18%
1-Month -2.45% -5.97% -0.75%
1-Year 96.38% 24.80% 61.82%
3-Year CAGR 89.34% 21.40% 18.16%
5-Year CAGR 38.20% 29.91% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Abbott India share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Abbott India the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Abbott India.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Abbott India paid Rs 325.0, and its dividend payout ratio stood at 72.7%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Abbott India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.